STEALTH BIOTHERAPEUTICS CORP (MITO) Stock Earnings & Estimates
NASDAQ:MITO - US85789A1051 - ADR
0.32 USD
0 (-1.36%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 21.09M | 17.85M -100.00% | |||||||||
| EBITDA YoY % growth | -79.37M -28.97% | -74.97M 5.54% | -45.55M 39.24% | N/A -6.34% | N/A 4.57% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -79.72M -28.89% | -75.28M 5.57% | -45.83M 39.12% | -32.446M -6.20% | -47.092M 4.86% | -47.943M -3.54% | -47.377M 1.18% | -48.312M -1.97% | -47.177M 2.35% | -46.99M 0.40% | |
| Operating Margin | N/A | N/A | -217.31% | -181.77% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -0.15 88.04% | -0.06 26.67% | -0.31 27.27% | -0.06 23.50% | -0.05 16.67% | -0.06 -20.00% | -0.06 3.59% | -0.06 1.67% |
All data in USD
| Q2 / 22 | Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.02 32.00% | -0.01 -2.00% | -0.01 66.00% | -0.01 -2.00% | -0.02 25.00% | -0.02 -50.00% | -0.01 | -0.02 -100.00% | -0.01 33.33% | -0.01 33.33% | -0.02 -100.00% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -11.73M -6.68% | -11.73M -2.48% | -11.73M 8.24% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2022 Q2Q % growth | -0.01 | -0.02 | 0.01 | 50.98% |
| Q4 2021 Q2Q % growth | -0.03 | -0.08 | 0.05 | 63.24% |
| Q3 2021 Q2Q % growth | -0.01 50.00% | -0.02 | 0.01 | 50.98% |
| Q2 2021 Q2Q % growth | -0.03 -50.00% | -0.02 | -0.01 | -47.06% |
| Q1 2021 Q2Q % growth | -0.01 75.00% | 0.00 | -0.01 | % |
| Q4 2020 Q2Q % growth | -0.03 -250.00% | 0.01 | -0.04 | -394.12% |
| Q3 2020 Q2Q % growth | -0.02 50.00% | -0.02 | 0.00 | 1.96% |
| Q2 2020 Q2Q % growth | -0.02 50.00% | -0.02 | 0.00 | 18.30% |
| Q1 2020 Q2Q % growth | -0.04 55.56% | -0.09 | 0.05 | 55.60% |
| Q4 2019 Q2Q % growth | 0.02 | -0.02 | 0.04 | 189.13% |
| Q3 2019 Q2Q % growth | -0.04 | -0.04 | 0.00 | 10.87% |
| Q2 2019 Q2Q % growth | -0.04 | -0.08 | 0.04 | 49.40% |
| Q1 2019 Q2Q % growth | -0.09 | -0.35 | 0.26 | 74.55% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2021 Q2Q % growth | 10.2M | -10.2M | -100.00% | |
| Q4 2020 Q2Q % growth | -100.00% | 17.85M | -17.85M | -100.00% |
| Q4 2019 Q2Q % growth | 21.09M | 9.18M | 11.91M | 129.74% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |